Neuroscience
Alzheimer's Disease
100%
Parkinson's Disease
56%
Mild Cognitive Impairment
37%
Neuropsychiatric Symptom
33%
Blood Plasma
24%
Antipsychotic
20%
Cognitive Disorders
19%
Neurodegenerative Disorder
16%
Long-Term Memory
14%
Meta-Analysis
14%
Entorhinal Cortex
11%
Down Syndrome
9%
Montreal Cognitive Assessment
8%
Serotonergic
8%
Lecithin
8%
Nuclear Magnetic Resonance Spectroscopy
7%
Cognitive Tests
7%
Gene Expression
7%
Dopamine Transporter
7%
Randomized Controlled Trial
6%
Functional Neuroimaging
6%
31P NMR Spectroscopy
6%
Dementia with Lewy Bodies
6%
Basal Ganglia
6%
Obsessive-Compulsive Disorder
6%
Psilocybin
6%
Major Depressive Disorder
6%
Gray Matter Volume
6%
Lumbar Puncture
6%
Endocannabinoid System
6%
Calcium Channel
6%
Ceramide
6%
Donepezil
6%
High Energy Phosphate
6%
Clusterin
6%
Cannabinoid
6%
Vascular Dementia
6%
Amlodipine
6%
Progressive Supranuclear Palsy
6%
Neurofilament
6%
Complement System
6%
Neurogenesis
6%
Cannabis
6%
Electroconvulsive Therapy
6%
Antidepressant
6%
Metabolic Pathway
5%
Drug Therapy
5%
Functional Magnetic Resonance Imaging
5%
Cholinergic
5%
Medicine and Dentistry
Alzheimer's Disease
54%
Parkinson's Disease
41%
COVID-19
36%
Mental Health Service
24%
Clinical Trial
22%
Mild Cognitive Impairment
21%
Neuropsychiatric Symptom
20%
Cognitive Defect
15%
Electronic Health Record
13%
Adverse Outcome
13%
Electroconvulsive Therapy
13%
Antipsychotic
13%
Patient Referral
13%
Hallucination
12%
Biological Marker
11%
Mental Health
10%
Health Care Cost
10%
Diabetes
10%
Disease Exacerbation
10%
Montreal Cognitive Assessment
10%
Diseases
8%
Patient with Alzheimer's Disease
8%
Clinician
8%
Treatment Response
8%
Mini-Mental State Examination
8%
Delusion
8%
Clinical Research
7%
Cognitive Assessment
7%
Tau
6%
Radioactive Tracer
6%
PET-MRI
6%
Amyloid Protein
6%
Long Term Memory
6%
Functional Neuroimaging
6%
Retrospective Cohort Study
6%
Parkinson's Disease Clinical Trial
6%
Early-Onset Alzheimer's Disease
6%
Systematic Review
6%
Maturity Onset Diabetes of the Young
6%
Randomized Controlled Trial
6%
Down Syndrome
6%
Allele
6%
Amlodipine
6%
Calcium Channel
6%
Donepezil
6%
Influenza Vaccine
6%
Vascular Dementia
6%
Lumbar Puncture
6%
Hopkins Verbal Learning Test
6%
Genome Wide Association Study
6%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
52%
Parkinson's Disease
34%
Antipsychotic
20%
Clinical Trial
16%
Diseases
15%
Adverse Outcome
13%
Cannabinoid
13%
Tolerability
13%
Adverse Event
13%
Quetiapine
11%
Randomized Controlled Trial
7%
Mild Cognitive Impairment
7%
Typical Antipsychotic
6%
Pandemic
6%
Cohort Study
6%
Endogenous Psychosis
6%
Endocannabinoid System
6%
DSM-IV
6%
Calcium Channel
6%
Donepezil
6%
Non Insulin Dependent Diabetes Mellitus
6%
Myoclonus
6%
Observational Study
6%
Open-Label Trial
6%
Multiinfarct Dementia
6%
Disease Exacerbation
6%
Amlodipine
6%
Diffuse Lewy Body Disease
6%
Progressive Supranuclear Palsy
6%
Syndrome
6%
Cognitive Defect
6%
Side Effect
5%
Comorbidity
5%
Cholinergic Receptor Stimulating Agent
5%
Antidepressant
5%
